Mml Investors Services »

Iovance Biotherapeutics shares owned by Mml Investors Services

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Mml Investors Services from 13F filings

Historical chart of Mml Investors Services investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Mml Investors Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Mml Investors Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $305k 112k 2.73

More positions owned by Mml Investors Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Mml Investors Services

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Invenomic Capital Management
Goldman Sachs Group
Long Focus Capital Management
Geode Capital Management
Palo Alto Investors
Susquehanna International
Citadel Advisors
Millennium Management
Hrt Financial
Jane Street
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics